The detective work was excellent
Not every peptide program is appropriate for every patient
doi: 10.1136/heartjnl-2019-316376 [PubMed] [CrossRef] [Google Scholar] Cosentino F., et al., 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Here's how they compare: Peptide Primary research area FDA status Advisory committee review BPC-157 Tissue repair, angiogenesis Not approved Yes (free base + acetate) TB-500 Actin regulation, cell migration Not approved Yes MOTS-c Mitochondrial metabolism Not approved Yes KPV Anti-inflammatory Not approved Yes GHK-Cu Copper-peptide skin/healing Not approved Not on 2026 agenda For a deeper comparison of BPC-157 and its most-researched counterpart, see our BPC-157 vs TB-500 research comparison
You believe that an effective cosmetic product should not be damaging to your skin
Figure 1 2.1 The impact of Gln metabolism on tumor promotion 2.1.1 Promotion of tumor cell proliferation and metastasis Gln metabolism is intricately linked to tumor proliferation and migration
